RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 88 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,360 | -99.4% | 19,200 | -97.1% | 0.00% | -100.0% |
| Q2 2022 | $564,000 | -68.5% | 662,593 | +104.1% | 0.00% | -60.0% |
| Q1 2022 | $1,789,000 | -35.6% | 324,661 | +13.1% | 0.01% | -16.7% |
| Q4 2021 | $2,778,000 | -37.0% | 286,967 | +16.4% | 0.01% | -40.0% |
| Q3 2021 | $4,409,000 | +21.5% | 246,566 | +65.9% | 0.01% | +25.0% |
| Q2 2021 | $3,629,000 | +2196.8% | 148,656 | +616.2% | 0.01% | – |
| Q4 2020 | $158,000 | -33.1% | 20,755 | -55.9% | 0.00% | -100.0% |
| Q3 2020 | $236,000 | -43.4% | 47,091 | -32.5% | 0.00% | -50.0% |
| Q2 2020 | $417,000 | +4.5% | 69,719 | -22.3% | 0.00% | -33.3% |
| Q1 2020 | $399,000 | – | 89,701 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 38,296,526 | $290,671,000 | 5.29% |
| HARBOURVEST PARTNERS LLC | 986,878 | $7,490,000 | 2.93% |
| Abbot Financial Management, Inc. | 537,000 | $4,076,000 | 2.35% |
| Artal Group S.A. | 3,778,913 | $28,682,000 | 0.62% |
| HITE Hedge Asset Management LLC | 88,740 | $674,000 | 0.16% |
| Virtus ETF Advisers LLC | 33,793 | $256,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 394,909 | $2,997,000 | 0.03% |
| Baillie Gifford | 4,710,061 | $35,749,000 | 0.02% |
| Caption Management, LLC | 86,000 | $652,000 | 0.02% |
| Blueshift Asset Management, LLC | 14,626 | $111,000 | 0.01% |